Four Million Americans Could Lose Health Coverage Once ACA Credits Expire
By Carole Tanzer Miller HealthDay Reporter
WEDNESDAY, Nov. 20, 2024 -- If Congress lets healthcare tax credits established during the pandemic expire, 4 million Americans will become uninsured, a new analysis warns.
The tax credits, which have significantly lowered out-of-pocket costs for millions of Americans, are set to expire at the end of 2025.
"Allowing these credits to expire will force families to choose between healthcare and other necessities like housing and food," said Katherine Hempstead, a senior policy adviser at the Robert Wood Johnson Foundation (RWJF). It supported the analysis and an interactive data simulation, which were conducted by a team at the Urban Institute, a public policy think tank.
"The implications will be profound, with the ripple effects being felt across the entire U.S. economy," she added in a RWJF news release.
Congress introduced the tax credits in 2021 to help Americans maintain health insurance overage during the pandemic. Congress renewed them a year later.
The Urban Institute's new analysis examines how insurance coverage rates would be affected in all 50 states and the impact on people of various races, ethnicities, ages and income levels.
"If the enhanced premium tax credits expire, there will be dramatic declines in Marketplace coverage and increases in uninsurance, but the effects will not be felt equally across state or by race, income and age," said Jessica Banthin, a senior fellow at the Urban Institute.
"Our analysis shows that their expiration could mean some communities may experience greater coverage losses, making healthcare unaffordable and inaccessible," she added.
Of the estimated 4 million people who would no longer be able to afford health coverage, nearly 2.5 million live in states that have not expanded Medicaid eligibility under the Affordable Care Act (ACA), also known as Obamacare.
Southern states would be hard hit. Mississippi is projected to have the largest increase in uninsured residents -- 112,000 people in all -- followed by Alabama, Louisiana, Georgia, Tennessee and South Carolina. The percentage of uninsured people would rise in those states by more than 30%, according to the analysis.
At the same time, enrollment in subsidized plans offered through the ACA Marketplace is projected to fall by 7.2 million Americans. Of those, 4.5 million live in states that have not expanded Medicaid eligibility, according to the study.
Subsidized Marketplace coverage is projected to drop by more than 60% in Louisiana, Kentucky and Texas alone.
The report warns that 1.1 million Black Americans stand to lose subsidized health coverage through the ACA -- mostly in non-expansion states. A similar number of Hispanic people -- 1.3 million -- would be affected the same way.
More than half of the 4.3 million white Americans who stand to lose subsidized ACA coverage also live in non-expansion states.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-21 00:00
Read more
- U.S. Overdose Deaths Fell 17% in Just One Year
- Sixty Waterborne Disease Outbreaks Tied to Splash Pads From 1997 to 2022
- Moderate-to-Vigorous Exercise Lowers Preterm Birth Risk With Gestational Diabetes
- FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
- Biomarkers of Insulin Resistance Are Risk Factors for Aortic Stenosis
- As Daily Steps Rise, Depression Levels Fall
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions